CARLYN WIKAR: Open Payments
NPI 1891475133 · SWAMPSCOTT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 15 payments from 8 companies in 2025. Trend: 2023 $142 · 2024 $667 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $136 |
| Lilly USA, LLC | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| UCB, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $32 |
| Incyte Corporation | 1 | $30 |
| Galderma Laboratories, L.P. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: TREMFYA, TALTZ, Sotyktu, Bimzelx, CIBINQO, OPZELURA, NEMLUVIO, COSENTYX.
Industry payments across MA — which companies pay providers there.
